Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
US Department of Justice
Covington
Cerilliant
Baxter
Cipla
Novartis
McKesson
QuintilesIMS
Federal Trade Commission

Generated: August 23, 2017

DrugPatentWatch Database Preview

Details for United Kingdom Supplementary Protection Certificate: SPC/GB07/047

« Back to Dashboard

These international patent data are derived from patent families, based on US drug-patent linkages.
They should not be regarded as comprehensive records of ex-US drug-patent associations.

Country Document Number Supplementary Protection Certificate SPC Country SPC Description SPC Expiration
European Patent Office 0925294 SPC/GB07/047 United Kingdom SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB07/047 GRANTED TO CELGENE CORPORATION IN RESPECT OF THE PRODUCT LENALIDOMIDE (COMMON NAME) 1-OXO-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-AMINOSOINDOLINE OPTIONALLY IN THE FORM OF AN ACID ADDITION SALT , THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6228 DATED 01 OCTOBER 2008, AND THE CORRECTION OF WHICH WAS ADVERTISED IN JOURNAL NO 6523 DATED 28 MAY 2014, HAS HAD ITS MAXIMUM PERIOD OF DURATION FURTHER CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 18 JUNE 2022. ► Subscribe
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Colorcon
Moodys
Queensland Health
Johnson and Johnson
Cantor Fitzgerald
Citi
McKesson
UBS
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot